We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
bioAffinity Technologies Inc | NASDAQ:BIAF | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -0.48% | 2.07 | 2.03 | 2.11 | 2.103 | 1.99 | 2.05 | 43,641 | 22:16:27 |
FORM 3
| Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Zannes Maria |
2. Date of Event Requiring Statement (MM/DD/YYYY)
| 3. Issuer Name and Ticker or Trading Symbol bioAffinity Technologies, Inc. [BIAF] |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) President, CEO / | ||
5. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned | |||
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock, par value $0.007 (1) | 3571 (2) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Unsecured Convertible Promissory Note (1) | 9/6/2022 | 10/31/2022 | Common Stock | 23672 (3) | $4.20 | D | |
Stock Option (right to buy) (1) | (4) | 4/28/2024 | Common Stock | 64848 | $1.16 | D | |
Stock Option (right to buy) (1) | (5) | 7/27/2025 | Common Stock | 3571 | $4.20 | D | |
Stock Option (right to buy) (1) | (6) | 7/25/2026 | Common Stock | 3571 | $7.00 | D | |
Stock Option (right to buy) (1) | (7) | 4/24/2027 | Common Stock | 3571 | $7.00 | D | |
Stock Option (right to buy) (1) | (8) | 5/7/2028 | Common Stock | 7142 | $7.70 | D | |
Stock Option (right to buy) (1) | (9) | 2/25/2029 | Common Stock | 2857 | $7.70 | D | |
Stock Option (right to buy) (1) | (10) | 7/29/2029 | Common Stock | 7142 | $7.70 | D | |
Stock Option (right to buy) (1) | (11) | 2/5/2030 | Common Stock | 7142 | $7.70 | D | |
Stock Option (right to buy) (1) | (12) | 7/27/2030 | Common Stock | 7142 | $7.70 | D | |
Stock Option (right to buy) (1) | (13) | 7/26/2031 | Common Stock | 7142 | $7.70 | D | |
Stock Option (right to buy) (1) | (14) | 12/16/2031 | Common Stock | 7142 | $4.20 | D |
Remarks: Exhibit List - Exhibit 24.1: Power of Attorney (Maria Zannes) |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Zannes Maria 19702 BELLA LOMA, #6005 SAN ANTONIO, TX 78256 | X | President, CEO |
Signatures | ||
/s/ Wilhelm E. Liebmann, as attorney-in-fact for Maria Zannes | 11/22/2022 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year bioAffinity Technologies Chart |
1 Month bioAffinity Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions